Literature DB >> 27676455

Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.

M Y Shino1, S S Weigt1, N Li2, A Derhovanessian1, D M Sayah1, R H Huynh1, R Saggar1, A L Gregson3, A Ardehali4, D J Ross1, J P Lynch1, R M Elashoff2, J A Belperio1.   

Abstract

The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD) remains unknown. We hypothesized that episodes of late-onset (≥6 months) allograft injury would produce an augmented CXCR3/ligand immune response, leading to increased CLAD. In a retrospective single-center study, 1894 transbronchial biopsy samples from 441 lung transplant recipients were reviewed for the presence of acute rejection (AR), lymphocytic bronchiolitis (LB), diffuse alveolar damage (DAD), and organizing pneumonia (OP). The association between the time of onset of each injury pattern and CLAD was assessed by using multivariable Cox models with time-dependent covariates. Bronchoalveolar lavage (BAL) CXCR3 ligand concentrations were compared between early- and late-onset injury patterns using linear mixed-effects models. Late-onset DAD and OP were strongly associated with CLAD: adjusted hazard ratio 2.8 (95% confidence interval 1.5-5.3) and 2.0 (1.1-3.4), respectively. The early-onset form of these injury patterns did not increase CLAD risk. Late-onset LB and acute rejection (AR) predicted CLAD in univariable models but lost significance after multivariable adjustment for late DAD and OP. AR was the only early-onset injury pattern associated with CLAD development. Elevated BAL CXCR3 ligand concentrations during late-onset allograft injury parallel the increase in CLAD risk and support our hypothesis that late allograft injuries result in a more profound CXCR3/ligand immune response.
© 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  chemokines/chemokine receptors; clinical research/practice; immunobiology; lung (allograft) function/dysfunction; lung failure/injury; lung transplantation/pulmonology; rejection: acute; rejection: chronic; translational research/science

Mesh:

Year:  2016        PMID: 27676455      PMCID: PMC5368037          DOI: 10.1111/ajt.14066

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   9.369


  61 in total

Review 1.  The role of Th1/Th2 polarization in mucosal immunity.

Authors:  Markus F Neurath; Susetta Finotto; Laurie H Glimcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

2.  The significance of a single episode of minimal acute rejection after lung transplantation.

Authors:  Ramsey R Hachem; Anthony P Khalifah; Murali M Chakinala; Roger D Yusen; Aviva A Aloush; Thalachallour Mohanakumar; G Alexander Patterson; Elbert P Trulock; Michael J Walter
Journal:  Transplantation       Date:  2005-11-27       Impact factor: 4.939

3.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

4.  Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation.

Authors:  Elfriede Ruttmann; Christian Geltner; Brigitte Bucher; Hanno Ulmer; Daniel Höfer; Herbert B Hangler; Severin Semsroth; Raimund Margreiter; Günther Laufer; Ludwig C Müller
Journal:  Transplantation       Date:  2006-05-27       Impact factor: 4.939

5.  The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation.

Authors:  Tim S Nawrot; Robin Vos; Lotte Jacobs; Stijn E Verleden; Shana Wauters; Veerle Mertens; Christophe Dooms; Peter H Hoet; Dirk E Van Raemdonck; Christel Faes; Lieven J Dupont; Benoit Nemery; Geert M Verleden; Bart M Vanaudenaerde
Journal:  Thorax       Date:  2011-03-23       Impact factor: 9.139

6.  Interstitial inflammatory lesions of the pulmonary allograft: a retrospective analysis of 2697 transbronchial biopsies.

Authors:  Christopher M Burton; Martin Iversen; Jørn Carlsen; Claus B Andersen
Journal:  Transplantation       Date:  2008-09-27       Impact factor: 4.939

7.  Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis.

Authors:  Peter M Hopkins; Christina L Aboyoun; Prashant N Chhajed; Monique A Malouf; Marshall L Plit; Stephen P Rainer; Allan R Glanville
Journal:  Am J Respir Crit Care Med       Date:  2004-08-05       Impact factor: 21.405

8.  Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: a retrospective analysis of 2697 transbronchial biopsies.

Authors:  Christopher M Burton; Martin Iversen; Thomas Scheike; Jørn Carlsen; Claus B Andersen
Journal:  Transplantation       Date:  2008-02-27       Impact factor: 4.939

9.  Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.

Authors:  D Heng; L D Sharples; K McNeil; S Stewart; T Wreghitt; J Wallwork
Journal:  J Heart Lung Transplant       Date:  1998-12       Impact factor: 10.247

10.  CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction.

Authors:  Michael Y Shino; S Samuel Weigt; Ning Li; Vyacheslav Palchevskiy; Ariss Derhovanessian; Rajan Saggar; David M Sayah; Aric L Gregson; Michael C Fishbein; Abbas Ardehali; David J Ross; Joseph P Lynch; Robert M Elashoff; John A Belperio
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

View more
  6 in total

1.  Airway Epithelial Telomere Dysfunction Drives Remodeling Similar to Chronic Lung Allograft Dysfunction.

Authors:  Ram P Naikawadi; Gary Green; Kirk D Jones; Natalia Achtar-Zadeh; Julia E Mieleszko; Isabel Arnould; Jasleen Kukreja; John R Greenland; Paul J Wolters
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

2.  CCR4 expression on host T cells is a driver for alloreactive responses and lung rejection.

Authors:  Vyacheslav Palchevskiy; Ying Ying Xue; Rita Kern; Stephen S Weigt; Aric L Gregson; Sophie X Song; Michael C Fishbein; Cory M Hogaboam; David M Sayah; Joseph P Lynch; Michael P Keane; David G Brooks; John A Belperio
Journal:  JCI Insight       Date:  2019-05-14

3.  Bronchiolitis obliterans syndrome susceptibility and the pulmonary microbiome.

Authors:  Cody Schott; S Samuel Weigt; Benjamin A Turturice; Ahmed Metwally; John Belperio; Patricia W Finn; David L Perkins
Journal:  J Heart Lung Transplant       Date:  2018-04-26       Impact factor: 10.247

4.  Secondary organizing pneumonia following occupational acute nitrogen oxide poisoning: a case report.

Authors:  Shuang Ma; Baotian Kan; Xiangdong Jian; Chenglin Li; Yingying Zheng; Cece Sun; Yiming Tao; Siqi Cui; Tianzi Jian
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

Review 5.  Oscillometry of the respiratory system: a translational opportunity not to be missed.

Authors:  Lennart K A Lundblad; Annette Robichaud
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-04-06       Impact factor: 5.464

6.  Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid.

Authors:  Laneshia K Tague; Derek E Byers; Ramsey Hachem; Daniel Kreisel; Alexander S Krupnick; Hrishikesh S Kulkarni; Catherine Chen; Howard J Huang; Andrew Gelman
Journal:  Pharmacogenomics J       Date:  2019-04-17       Impact factor: 3.550

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.